'Activity Pacing' in PLWH With Fatigue Symptoms.
- Conditions
- Hiv
- Registration Number
- NCT05194059
- Lead Sponsor
- Scientific Institute San Raffaele
- Brief Summary
Physical activity helps to improve health and prevent chronic diseases. However, the fatigue usually hampers the training and execution of physical exercises, especially in people with chronic fatigue syndromes (CFCs), such as persons living with HIV (PLWH). We hypothesize that the "activity pacing", i.e. the strategy to optimize daily physical activity into manageable exercises in a way that should not exacerbate fatigue symptoms, may help a progressive improvement in physical activity of a group of PLWH with fatigue symptoms. Motivation and adherence to exercise will be monitored through the use of digital supports.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 24
- of age ≥18 years;
- either sedentary or already practicing mild/moderate physical activity (at least 150 minutes of moderate-intensity physical activity throughout the week);
- able to sign the informed consent.
The study will exclude HIV+ individuals:
- with any HIV-related disease requiring hospitalization in the 6 weeks before enrolment;
- with medical conditions (e.g. neurologic, muscular-skeletal, cardiovascular diseases) contraindicating non agonistic exercise, as established by a sport medicine specialist;
- currently abusing of substance or alcohol;
- already performing physical activity at higher level than the current WHO recommendations (30 minutes of moderate activity 5 times a week).
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Activity pacing improvement 16 week To compare the improvement in the physical fitness between the Experimental Group and Control Group
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Department of Infectious Diseases
🇮🇹Milan, Italy
Department of Infectious Diseases🇮🇹Milan, Italy